1. Salpietro, Vincenzo, Dixon, Christine L, Guo, Hui, Kullmann, Dimitri M, Houlden, Henry. 2019. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. In Nature communications, 10, 3094. doi:10.1038/s41467-019-10910-w. https://pubmed.ncbi.nlm.nih.gov/31300657/
2. Vivero, Marina, Doyle, Leona A, Fletcher, Christopher D M, Mertens, Fredrik, Hornick, Jason L. 2014. GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling. In Histopathology, 65, 71-80. doi:10.1111/his.12377. https://pubmed.ncbi.nlm.nih.gov/24456377/
3. Zhang, Kai, Wang, Qingzhong, Jing, Xuxiu, Yu, Shunying, Zhao, Min. 2016. miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder. In Scientific reports, 6, 35691. doi:10.1038/srep35691. https://pubmed.ncbi.nlm.nih.gov/27767084/
4. Zhou, Mi, Qi, Lixing, Gu, Yongquan. 2021. GRIA2/ENPP3 Regulates the Proliferation and Migration of Vascular Smooth Muscle Cells in the Restenosis Process Post-PTA in Lower Extremity Arteries. In Frontiers in physiology, 12, 712400. doi:10.3389/fphys.2021.712400. https://pubmed.ncbi.nlm.nih.gov/34504438/
5. Pan, Yuhualei, Zhang, Jian-Hua, Zhao, Lianhe, Wang, Huan, Zhu, Yan-Bing. 2020. A robust two-gene signature for glioblastoma survival prediction. In Journal of cellular biochemistry, 121, 3593-3605. doi:10.1002/jcb.29653. https://pubmed.ncbi.nlm.nih.gov/31960992/